JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263407

Human UCK1 (UCK) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

UCK1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon1 and 1 bp deletion in exon1.

View Alternative Names

Cytidine monophosphate kinase, Cytidine monophosphokinase 1, Cytidylate kinase, Deoxycytidylate kinase, FLJ12255, OTTHUMP00000022400, OTTHUMP00000022401, OTTHUMP00000022403, OTTHUMP00000022404, RP11-334J6.5, UCK1_HUMAN, UMP-CMP kinase, URK1, Uridine monophosphokinase 1, Uridine-cytidine kinase 1, Uridine/cytidine kinase 1

2 Images
Sanger Sequencing - Human UCK1 (UCK) knockout HEK-293T cell lysate (AB263407)
  • Sanger seq

Unknown

Sanger Sequencing - Human UCK1 (UCK) knockout HEK-293T cell lysate (AB263407)

Allele-1 : 10 bp deletion in exon1

Sanger Sequencing - Human UCK1 (UCK) knockout HEK-293T cell lysate (AB263407)
  • Sanger seq

Unknown

Sanger Sequencing - Human UCK1 (UCK) knockout HEK-293T cell lysate (AB263407)

Allele-2 : 1 bp deletion in exon1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon1 and 1 bp deletion in exon1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263407-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human UCK1 knockout HEK293T cell lysate", "number":"AB263407-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB263407-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
UCK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Uridine-cytidine kinase (UCK) also known as uridine monophosphate kinase catalyzes the phosphorylation of uridine and cytidine to form uridine monophosphate (UMP) and cytidine monophosphate (CMP) respectively. This enzyme weighs about 30 kilodaltons. UCK expresses mostly in the cytoplasm with notable activity in tissues like the liver pancreas and kidney. Its function hinges on its ability to regulate nucleotide levels which are essential for nucleic acid metabolism.
Biological function summary

Uridine-cytidine kinase supports nucleotide homeostasis in cells. It does not form part of a larger enzymatic complex. This enzyme facilitates the salvage pathway converting nucleosides back into nucleotides. Such activity ensures sufficient nucleotide precursors for DNA and RNA synthesis which is critical during cell division and repair. Therefore disruptions in UCK function can severely impact cellular metabolism and proliferation.

Pathways

Nucleoside and nucleotide metabolism are key areas where uridine-cytidine kinase plays a prominent role. It particularly influences the pyrimidine salvage pathway an important process that helps recycle nucleotides within the cell. UCK interacts with other enzymes such as cytidine monophosphate kinase (CMP kinase) which further phosphorylates CMP into cytidine diphosphate (CDP). Proper functioning of these pathways ensures cellular nucleotide balance and genome integrity.

Abnormalities in uridine-cytidine kinase activity link to certain cancers and metabolic disorders. For example altered UCK activity has connections to cancer types where fast-proliferating cells show increased demand for nucleotides. Furthermore UCK changes have been associated with mitochondrial neurogastrointestinal encephalopathy (MNGIE). This disorder connects with dysfunctional thymidine phosphorylase highlighting the importance of nucleotide metabolism coordination. These insights help target UCK in therapeutic strategies for such diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com